Introduction of multi-dose PCV 13 vaccine in Benin: from the decision to vaccinators experience.

ABSTRACT:

Background

In 2011, Benin introduced the 13-valent pneumococcal conjugated vaccine (PCV13), in a single-dose vial, into its Expanded Programme for Immunisation (EPI) with support from Gavi. In April 2018, with the support of the Agence de Médecine Préventive Afrique (AMP) and other technical and financial partners, the single-dose vial was transitioned to a four-dose vial. Here we describe the decision-making process and the experience of the vaccinators during the change.

Methods

We carried out semi-structured, individual interviews with 61 participants individuals involved in the EPI: 7 from central level, 5 from regional level, 7 from township level and 42 from district level. The interviews were recorded and transcribed, and the information categorised, using Nvivo softw

SUBMITTER: Abdoulaye Alfa D 

PROVIDER: S-EPMC7414647 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature